Mepolizumab reduced exacerbations in patients with asthma and atopy, depression comorbiditiesMarch 2, 2021ObesityDepression
FDA expands sacubitril/valsartan indication to embrace some HFpEFFebruary 17, 2021CardiologyMixed Topics
Consider home subcutaneous immune globulin for refractory dermatomyositisFebruary 17, 2021Dermatology
Checkpoint inhibitors’ ‘big picture’ safety shown with preexisting autoimmune diseasesFebruary 16, 2021MelanomaOncologyDermatology
Cumulative exposure to high-potency topical steroid doses drives osteoporosis fracturesFebruary 16, 2021DermatologyGeriatrics
FDA approves first drug that protects against chemo-induced myelosuppressionFebruary 16, 2021Lung CancerOncology
‘Unprecedented’ long-term survival after immunotherapy in pretreated NSCLCFebruary 11, 2021Lung CancerOncology
